234 related articles for article (PubMed ID: 26756273)
41. Genome-wide analysis of genetic loci associated with Alzheimer disease.
Seshadri S; Fitzpatrick AL; Ikram MA; DeStefano AL; Gudnason V; Boada M; Bis JC; Smith AV; Carassquillo MM; Lambert JC; Harold D; Schrijvers EM; Ramirez-Lorca R; Debette S; Longstreth WT; Janssens AC; Pankratz VS; Dartigues JF; Hollingworth P; Aspelund T; Hernandez I; Beiser A; Kuller LH; Koudstaal PJ; Dickson DW; Tzourio C; Abraham R; Antunez C; Du Y; Rotter JI; Aulchenko YS; Harris TB; Petersen RC; Berr C; Owen MJ; Lopez-Arrieta J; Varadarajan BN; Becker JT; Rivadeneira F; Nalls MA; Graff-Radford NR; Campion D; Auerbach S; Rice K; Hofman A; Jonsson PV; Schmidt H; Lathrop M; Mosley TH; Au R; Psaty BM; Uitterlinden AG; Farrer LA; Lumley T; Ruiz A; Williams J; Amouyel P; Younkin SG; Wolf PA; Launer LJ; Lopez OL; van Duijn CM; Breteler MM; ; ;
JAMA; 2010 May; 303(18):1832-40. PubMed ID: 20460622
[TBL] [Abstract][Full Text] [Related]
42. No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients.
Middle F; Pritchard AL; Handoko H; Haque S; Holder R; Bentham P; Lendon CL
J Alzheimers Dis; 2010; 20(2):561-7. PubMed ID: 20182055
[TBL] [Abstract][Full Text] [Related]
43. The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.
Weamer EA; Emanuel JE; Varon D; Miyahara S; Wilkosz PA; Lopez OL; Dekosky ST; Sweet RA
Int Psychogeriatr; 2009 Feb; 21(1):78-85. PubMed ID: 18814807
[TBL] [Abstract][Full Text] [Related]
44. The genetics of Alzheimer disease.
Tanzi RE
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028126
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.
Zdanys KF; Kleiman TG; MacAvoy MG; Black BT; Rightmer TE; Grey M; Garman KS; Tampi RR; Gelernter J; van Dyck CH
Neuropsychopharmacology; 2007 Jan; 32(1):171-9. PubMed ID: 16841077
[TBL] [Abstract][Full Text] [Related]
46. Genetic studies on chromosome 12 in late-onset Alzheimer disease.
Wu WS; Holmans P; Wavrant-DeVrièze F; Shears S; Kehoe P; Crook R; Booth J; Williams N; Pérez-Tur J; Roehl K; Fenton I; Chartier-Harlin MC; Lovestone S; Williams J; Hutton M; Hardy J; Owen MJ; Goate A
JAMA; 1998 Aug; 280(7):619-22. PubMed ID: 9718053
[TBL] [Abstract][Full Text] [Related]
47. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
Deming Y; Li Z; Kapoor M; Harari O; Del-Aguila JL; Black K; Carrell D; Cai Y; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Huang KL; Bertelsen S; Fagan AM; Holtzman DM; Morris JC; Kim S; Saykin AJ; De Jager PL; Albert M; Moghekar A; O'Brien R; Riemenschneider M; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Schellenberg G; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Peskind ER; Li G; Di Narzo AF; ; ; Kauwe JS; Goate AM; Cruchaga C
Acta Neuropathol; 2017 May; 133(5):839-856. PubMed ID: 28247064
[TBL] [Abstract][Full Text] [Related]
48. Polygenic risk and hazard scores for Alzheimer's disease prediction.
Leonenko G; Sims R; Shoai M; Frizzati A; Bossù P; Spalletta G; Fox NC; Williams J; ; Hardy J; Escott-Price V
Ann Clin Transl Neurol; 2019 Mar; 6(3):456-465. PubMed ID: 30911569
[TBL] [Abstract][Full Text] [Related]
49. Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic review.
Creese B; Ballard C; Jones E
Dement Geriatr Cogn Disord; 2013; 35(3-4):155-64. PubMed ID: 23392273
[TBL] [Abstract][Full Text] [Related]
50. Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association.
Quaranta D; Bizzarro A; Marra C; Vita MG; Seripa D; Pilotto A; Sebastiani V; Mecocci P; Masullo C
J Alzheimers Dis; 2009; 16(1):173-80. PubMed ID: 19158433
[TBL] [Abstract][Full Text] [Related]
51. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.
Craig D; Hart DJ; Carson R; McIlroy SP; Passmore AP
Neurosci Lett; 2004 Sep; 368(1):33-6. PubMed ID: 15342129
[TBL] [Abstract][Full Text] [Related]
52. Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.
Szigeti K; Lal D; Li Y; Doody RS; Wilhelmsen K; Yan L; Liu S; Ma C;
J Alzheimers Dis; 2013; 33(2):517-23. PubMed ID: 23202439
[TBL] [Abstract][Full Text] [Related]
53. Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.
Kim J; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2017; 14(8):834-840. PubMed ID: 28219318
[TBL] [Abstract][Full Text] [Related]
54. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
Han MR; Schellenberg GD; Wang LS;
BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
[TBL] [Abstract][Full Text] [Related]
55. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease.
Hollingworth P; Hamshere ML; Moskvina V; Dowzell K; Moore PJ; Foy C; Archer N; Lynch A; Lovestone S; Brayne C; Rubinsztein DC; Lawlor B; Gill M; Owen MJ; Williams J
J Am Geriatr Soc; 2006 Sep; 54(9):1348-54. PubMed ID: 16970641
[TBL] [Abstract][Full Text] [Related]
56. Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families.
Liu L; Forsell C; Lilius L; Axelman K; Corder EH; Lannfelt L
Am J Med Genet; 1996 May; 67(3):306-11. PubMed ID: 8725748
[TBL] [Abstract][Full Text] [Related]
57. Molecular genetics of late-onset Alzheimer's disease.
Kamboh MI
Ann Hum Genet; 2004 Jul; 68(Pt 4):381-404. PubMed ID: 15225164
[TBL] [Abstract][Full Text] [Related]
58. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.
Holmes C; Smith H; Ganderton R; Arranz M; Collier D; Powell J; Lovestone S
J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):777-9. PubMed ID: 11723200
[TBL] [Abstract][Full Text] [Related]
59. A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution.
Zubenko GS; Hughes HB; Stiffler JS; Hurtt MR; Kaplan BB
Genomics; 1998 Jun; 50(2):121-8. PubMed ID: 9653640
[TBL] [Abstract][Full Text] [Related]
60. The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia.
Craig D; Hart DJ; McCool K; McIlroy SP; Passmore AP
Ann Neurol; 2004 Jul; 56(1):121-4. PubMed ID: 15236409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
